The Latest Analyst Ratings for Tandem Diabetes Care
Portfolio Pulse from Benzinga Insights
In the last quarter, Tandem Diabetes Care (NASDAQ:TNDM) received 1 bullish, 3 indifferent, and 1 somewhat bearish analyst rating. The average price target is $40.2, compared to the current price of $24.25, implying an upside. The average price target has decreased by 12.13% from the previous average of $45.75.
June 05, 2023 | 9:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tandem Diabetes Care has mixed analyst ratings with an average price target of $40.2, implying an upside from the current price of $24.25.
The mixed analyst ratings for Tandem Diabetes Care indicate uncertainty in the stock's performance. However, the average price target of $40.2 suggests an upside potential from the current price of $24.25. This could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100